CORD-19:2008f024274c53b0de1276f4047a6a641813fd98 / 279613-279724 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/2008f024274c53b0de1276f4047a6a641813fd98","sourcedb":"CORD-19","sourceid":"2008f024274c53b0de1276f4047a6a641813fd98","text":"Treatment was started with oral prednisone 2 mg/kg/d and cyclophosphamide pulses with a satisfactory evolution.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T80213","span":{"begin":0,"end":111},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T80213","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T40","span":{"begin":0,"end":111},"obj":"Sentence"}],"attributes":[{"subj":"T40","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T2674","span":{"begin":10,"end":13},"obj":"Disease"}],"attributes":[{"id":"A2674","pred":"mondo_id","subj":"T2674","obj":"http://purl.obolibrary.org/obo/MONDO_0010518"},{"subj":"T2674","pred":"source","obj":"CORD-19-PD-MONDO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#b293ec","default":true},{"id":"CORD-19_Custom_license_subset","color":"#93ec98"},{"id":"CORD-19-PD-MONDO","color":"#ec93a7"}]}]}}